Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-14

FDA Approved: RIVAROXABAN — Original Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved an original application for rivaroxaban (generic) from XLCare Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

ORIG AP for RIVAROXABAN (RIVAROXABAN)